NSC vs TSHA · P/E 18, rev $6.46B vs $640.7M cap
Norfolk Southern Corporation (NSC) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
NSC currently screens at market cap $60.10B and trailing P/E 18.2. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the NSC and TSHA stock pages for the full models.
Not investment advice.